SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 116 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $65,887 | -34.3% | 68,632 | -48.7% | 0.00% | – |
Q1 2023 | $100,346 | +92.8% | 133,795 | -5.2% | 0.00% | – |
Q4 2022 | $52,035 | -13.3% | 141,207 | +1.1% | 0.00% | – |
Q3 2022 | $60,000 | -7.7% | 139,607 | +66.9% | 0.00% | – |
Q2 2022 | $65,000 | -35.6% | 83,661 | +6.7% | 0.00% | – |
Q1 2022 | $101,000 | +98.0% | 78,418 | +94.0% | 0.00% | – |
Q4 2021 | $51,000 | -65.3% | 40,418 | -39.9% | 0.00% | – |
Q3 2021 | $147,000 | +47.0% | 67,262 | +152.8% | 0.00% | – |
Q2 2021 | $100,000 | -22.5% | 26,605 | -32.7% | 0.00% | – |
Q1 2021 | $129,000 | +1190.0% | 39,514 | +1217.6% | 0.00% | – |
Q4 2020 | $10,000 | -52.4% | 2,999 | -41.1% | 0.00% | – |
Q3 2020 | $21,000 | -79.6% | 5,095 | -83.3% | 0.00% | – |
Q2 2020 | $103,000 | +586.7% | 30,536 | +370.9% | 0.00% | – |
Q1 2020 | $15,000 | -97.5% | 6,484 | -96.0% | 0.00% | -100.0% |
Q4 2019 | $590,000 | +217.2% | 162,146 | +624.4% | 0.00% | +100.0% |
Q3 2019 | $186,000 | +313.3% | 22,382 | +331.1% | 0.00% | – |
Q4 2018 | $45,000 | -86.0% | 5,192 | -72.8% | 0.00% | -100.0% |
Q3 2018 | $321,000 | +43.9% | 19,106 | +79.8% | 0.00% | +50.0% |
Q2 2018 | $223,000 | +291.2% | 10,624 | +201.3% | 0.00% | +100.0% |
Q1 2018 | $57,000 | -31.3% | 3,526 | -19.4% | 0.00% | 0.0% |
Q4 2017 | $83,000 | +80.4% | 4,375 | -38.7% | 0.00% | 0.0% |
Q1 2017 | $46,000 | -17.9% | 7,138 | -43.3% | 0.00% | 0.0% |
Q4 2016 | $56,000 | -5.1% | 12,580 | +0.4% | 0.00% | 0.0% |
Q3 2016 | $59,000 | -16.9% | 12,533 | +16.7% | 0.00% | 0.0% |
Q2 2016 | $71,000 | -21.1% | 10,737 | -28.8% | 0.00% | 0.0% |
Q3 2015 | $90,000 | -61.4% | 15,072 | -60.7% | 0.00% | -75.0% |
Q1 2015 | $233,000 | -13.4% | 38,386 | -1.1% | 0.00% | 0.0% |
Q4 2014 | $269,000 | +13.0% | 38,808 | +33.0% | 0.00% | 0.0% |
Q3 2014 | $238,000 | +67.6% | 29,187 | +67.4% | 0.00% | +100.0% |
Q2 2014 | $142,000 | -8.4% | 17,435 | -11.8% | 0.00% | -33.3% |
Q1 2014 | $155,000 | -21.3% | 19,764 | -11.2% | 0.00% | 0.0% |
Q4 2013 | $197,000 | -32.3% | 22,256 | -42.9% | 0.00% | -57.1% |
Q2 2013 | $291,000 | – | 38,955 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |